Method: Shotgun metagenomic sequencing (CLIA 21D2062464); not cleared or approved by the FDA. Results reflect relative microbial abundance for wellness education purposes. Not intended to diagnose or treat disease and not a substitute for clinical consultation. Microbial associations are based on emerging scientific research and may change over time.
A derived biomarker is a value that is calculated from other directly measured biomarkers rather than being measured directly in the lab.
Key benefits of Blastocystis testing
- Blastocystis gut parasite monitoring
- prevalence and potential gut health association tracking
What is Blastocystis?
Blastocystis is one of the most common gut parasites found in humans globally, present in approximately 10-30% of tested populations (per published prevalence studies). Its clinical significance is debated - it may be commensal in some individuals and associated with gut symptoms in others. Detected by shotgun sequencing.
Why is Blastocystis important?
The role of Blastocystis in gut health is an active area of research. Some studies associate certain subtypes with irritable bowel symptoms; others suggest certain subtypes may even be associated with higher microbiome diversity. Subtype characterization requires dedicated follow-up testing.
What insights will I get?
Your Blastocystis result indicates whether this organism is detectable in your gut. If detected and you have gut symptoms, discuss this finding with your care team. Asymptomatic detection can be monitored over time.





.avif)
.avif)

